Pheochromocytoma differential diagnosis

Pheochromocytoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Pheochromocytoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Pheochromocytoma differential diagnosis On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pheochromocytoma differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pheochromocytoma differential diagnosis
CDC on Pheochromocytoma differential diagnosis
Pheochromocytoma differential diagnosis in the news
Blogs on Pheochromocytoma differential diagnosis
Directions to Hospitals Treating Pheochromocytoma
Risk calculators and risk factors for Pheochromocytoma differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Pheochromocytoma must be differentiated from anxiety, carcinoid, and hypoglycemia.

Differentiating Pheochromocytoma from other Diseases

The differential diagnosis of pheochromocytoma includes:

• Anxiety disorders
• Carcinoid tumor
• Paragangliomas
• Essential hypertension
• Hyperthyroidism
• Insulinoma
• Paroxysmal supraventricular tachycardia
• Renovascular hypertension
• Hypoglycemia
• Stress
• Exercise
• Medications such as stimulants, methyldopa, and dopamine agonists

References

Template:WikiDoc Sources